S&P 500   3,125.91 (-3.10%)
DOW   27,045.23 (-3.27%)
QQQ   215.28 (-2.76%)
AAPL   289.42 (-2.94%)
FB   197.36 (-1.68%)
MSFT   168.22 (-1.56%)
AMZN   1,967.02 (-2.10%)
CGC   19.61 (-3.45%)
BABA   205.06 (-0.53%)
MU   51.98 (-5.51%)
GE   11.20 (-5.56%)
TSLA   798.32 (-4.25%)
AMD   47.36 (-3.58%)
T   37.38 (-1.76%)
ACB   1.49 (-3.86%)
F   7.24 (-4.36%)
NFLX   360.06 (-2.34%)
BAC   31.08 (-5.04%)
DIS   128.29 (-3.55%)
GILD   69.23 (-5.03%)
S&P 500   3,125.91 (-3.10%)
DOW   27,045.23 (-3.27%)
QQQ   215.28 (-2.76%)
AAPL   289.42 (-2.94%)
FB   197.36 (-1.68%)
MSFT   168.22 (-1.56%)
AMZN   1,967.02 (-2.10%)
CGC   19.61 (-3.45%)
BABA   205.06 (-0.53%)
MU   51.98 (-5.51%)
GE   11.20 (-5.56%)
TSLA   798.32 (-4.25%)
AMD   47.36 (-3.58%)
T   37.38 (-1.76%)
ACB   1.49 (-3.86%)
F   7.24 (-4.36%)
NFLX   360.06 (-2.34%)
BAC   31.08 (-5.04%)
DIS   128.29 (-3.55%)
GILD   69.23 (-5.03%)
S&P 500   3,125.91 (-3.10%)
DOW   27,045.23 (-3.27%)
QQQ   215.28 (-2.76%)
AAPL   289.42 (-2.94%)
FB   197.36 (-1.68%)
MSFT   168.22 (-1.56%)
AMZN   1,967.02 (-2.10%)
CGC   19.61 (-3.45%)
BABA   205.06 (-0.53%)
MU   51.98 (-5.51%)
GE   11.20 (-5.56%)
TSLA   798.32 (-4.25%)
AMD   47.36 (-3.58%)
T   37.38 (-1.76%)
ACB   1.49 (-3.86%)
F   7.24 (-4.36%)
NFLX   360.06 (-2.34%)
BAC   31.08 (-5.04%)
DIS   128.29 (-3.55%)
GILD   69.23 (-5.03%)
S&P 500   3,125.91 (-3.10%)
DOW   27,045.23 (-3.27%)
QQQ   215.28 (-2.76%)
AAPL   289.42 (-2.94%)
FB   197.36 (-1.68%)
MSFT   168.22 (-1.56%)
AMZN   1,967.02 (-2.10%)
CGC   19.61 (-3.45%)
BABA   205.06 (-0.53%)
MU   51.98 (-5.51%)
GE   11.20 (-5.56%)
TSLA   798.32 (-4.25%)
AMD   47.36 (-3.58%)
T   37.38 (-1.76%)
ACB   1.49 (-3.86%)
F   7.24 (-4.36%)
NFLX   360.06 (-2.34%)
BAC   31.08 (-5.04%)
DIS   128.29 (-3.55%)
GILD   69.23 (-5.03%)
Log in

NYSE:JNJ - Johnson & Johnson Stock Price, Forecast & News

$144.10
-1.81 (-1.24 %)
(As of 02/25/2020 02:38 PM ET)
Today's Range
$143.84
Now: $144.10
$146.75
50-Day Range
$144.10
MA: $148.93
$153.99
52-Week Range
$126.10
Now: $144.10
$154.50
Volume5.30 million shs
Average Volume6.79 million shs
Market Capitalization$379.66 billion
P/E Ratio21.25
Dividend Yield2.53%
Beta0.69
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
CUSIP47816010
Phone732-524-0400

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$82.06 billion
Cash Flow$11.07 per share
Book Value$22.60 per share

Profitability

Net Income$15.12 billion

Miscellaneous

Employees132,200
Outstanding Shares2,634,721,000
Market Cap$379.66 billion
Next Earnings Date4/21/2020 (Estimated)
OptionableOptionable

Receive JNJ News and Ratings via Email

Sign-up to receive the latest news and ratings for JNJ and its competitors with MarketBeat's FREE daily newsletter.


Johnson & Johnson (NYSE:JNJ) Frequently Asked Questions

What is Johnson & Johnson's stock symbol?

Johnson & Johnson trades on the New York Stock Exchange (NYSE) under the ticker symbol "JNJ."

How often does Johnson & Johnson pay dividends? What is the dividend yield for Johnson & Johnson?

Johnson & Johnson announced a quarterly dividend on Thursday, January 2nd. Stockholders of record on Tuesday, February 25th will be paid a dividend of $0.95 per share on Tuesday, March 10th. This represents a $3.80 annualized dividend and a dividend yield of 2.63%. The ex-dividend date is Monday, February 24th. View Johnson & Johnson's Dividend History.

How will Johnson & Johnson's stock buyback program work?

Johnson & Johnson declared that its Board of Directors has approved a stock buyback plan on Monday, December 17th 2018, which permits the company to buyback $5,000,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to reacquire up to 1.5% of its shares through open market purchases. Shares buyback plans are typically an indication that the company's board of directors believes its stock is undervalued.

How were Johnson & Johnson's earnings last quarter?

Johnson & Johnson (NYSE:JNJ) posted its quarterly earnings data on Wednesday, January, 22nd. The company reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.87 by $0.01. The firm had revenue of $20.75 billion for the quarter, compared to the consensus estimate of $20.83 billion. Johnson & Johnson had a net margin of 22.18% and a return on equity of 39.27%. The company's revenue for the quarter was up 1.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.97 EPS. View Johnson & Johnson's Earnings History.

When is Johnson & Johnson's next earnings date?

Johnson & Johnson is scheduled to release their next quarterly earnings announcement on Tuesday, April 21st 2020. View Earnings Estimates for Johnson & Johnson.

What guidance has Johnson & Johnson issued on next quarter's earnings?

Johnson & Johnson issued an update on its FY20 earnings guidance on Wednesday, January, 22nd. The company provided earnings per share (EPS) guidance of $8.95-9.10 for the period, compared to the Thomson Reuters consensus EPS estimate of $9.09. The company issued revenue guidance of +4.5-5.5% yr/yr to $85.8-86.2 billion, compared to the consensus revenue estimate of $85.52 billion.

What price target have analysts set for JNJ?

13 equities research analysts have issued 1-year target prices for Johnson & Johnson's stock. Their forecasts range from $147.00 to $173.00. On average, they anticipate Johnson & Johnson's share price to reach $162.27 in the next year. This suggests a possible upside of 12.2% from the stock's current price. View Analyst Price Targets for Johnson & Johnson.

What is the consensus analysts' recommendation for Johnson & Johnson?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Johnson & Johnson in the last year. There are currently 3 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Johnson & Johnson.

Has Johnson & Johnson been receiving favorable news coverage?

Media coverage about JNJ stock has been trending very negative this week, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Johnson & Johnson earned a coverage optimism score of -3.0 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for Johnson & Johnson.

Who are some of Johnson & Johnson's key competitors?

What other stocks do shareholders of Johnson & Johnson own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Johnson & Johnson investors own include AT&T (T), Walt Disney (DIS), Verizon Communications (VZ), Cisco Systems (CSCO), Procter & Gamble (PG), Intel (INTC), Pfizer (PFE), JPMorgan Chase & Co. (JPM), Home Depot (HD) and Exxon Mobil (XOM).

Who are Johnson & Johnson's key executives?

Johnson & Johnson's management team includes the folowing people:
  • Mr. Alex Gorsky, Chairman & CEO (Age 59)
  • Mr. Joseph J. Wolk CPA, Exec. VP & CFO (Age 52)
  • Dr. Paulus A. Stoffels, Chief Scientific Officer (Age 57)
  • Mr. Michael H. Ullmann, Exec. VP & Gen. Counsel (Age 60)
  • Mr. Joaquin Duato, Vice Chairman of Exec. Committee (Age 56)

Who are Johnson & Johnson's major shareholders?

Johnson & Johnson's stock is owned by many different of retail and institutional investors. Top institutional shareholders include State Street Corp (5.76%), Geode Capital Management LLC (1.46%), Bank of New York Mellon Corp (1.25%), Massachusetts Financial Services Co. MA (1.04%), FMR LLC (0.68%) and Capital International Investors (0.56%). Company insiders that own Johnson & Johnson stock include Alex Gorsky, Charles Prince, Hubert Joly, Joaquin Duato, Kathryn E Wengel, Marillyn A Hewson, Michael E Sneed, Peter Fasolo and Ronald A Kapusta. View Institutional Ownership Trends for Johnson & Johnson.

Which institutional investors are selling Johnson & Johnson stock?

JNJ stock was sold by a variety of institutional investors in the last quarter, including Capital World Investors, Capital International Investors, Renaissance Technologies LLC, Assenagon Asset Management S.A., Yacktman Asset Management LP, Great West Life Assurance Co. Can, Standard Life Aberdeen plc and PGGM Investments. Company insiders that have sold Johnson & Johnson company stock in the last year include Kathryn E Wengel and Michael E Sneed. View Insider Buying and Selling for Johnson & Johnson.

Which institutional investors are buying Johnson & Johnson stock?

JNJ stock was bought by a variety of institutional investors in the last quarter, including Johanson Financial Advisors Inc., Amundi Pioneer Asset Management Inc., M&G Investment Management Ltd., Alliancebernstein L.P., Geode Capital Management LLC, Franklin Resources Inc., Bank of New York Mellon Corp and Massachusetts Financial Services Co. MA. Company insiders that have bought Johnson & Johnson stock in the last two years include Charles Prince, Hubert Joly and Marillyn A Hewson. View Insider Buying and Selling for Johnson & Johnson.

How do I buy shares of Johnson & Johnson?

Shares of JNJ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Johnson & Johnson's stock price today?

One share of JNJ stock can currently be purchased for approximately $144.61.

How big of a company is Johnson & Johnson?

Johnson & Johnson has a market capitalization of $381.00 billion and generates $82.06 billion in revenue each year. The company earns $15.12 billion in net income (profit) each year or $8.68 on an earnings per share basis. Johnson & Johnson employs 132,200 workers across the globe.View Additional Information About Johnson & Johnson.

What is Johnson & Johnson's official website?

The official website for Johnson & Johnson is http://www.jnj.com/.

How can I contact Johnson & Johnson?

Johnson & Johnson's mailing address is ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK NJ, 08933. The company can be reached via phone at 732-524-0400.


MarketBeat Community Rating for Johnson & Johnson (NYSE JNJ)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  933 (Vote Outperform)
Underperform Votes:  999 (Vote Underperform)
Total Votes:  1,932
MarketBeat's community ratings are surveys of what our community members think about Johnson & Johnson and other stocks. Vote "Outperform" if you believe JNJ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe JNJ will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/25/2020 by MarketBeat.com Staff

Featured Article: Risk Tolerance

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel